Article Details

Zacks Investment Research Lowers Bioamber (BIOA) to Sell

Retrieved on: 2018-01-05 21:21:09

Tags for this article:

Click the tags to see associated articles and topics

Zacks Investment Research Lowers Bioamber (BIOA) to Sell. View article details on hiswai:

Excerpt

<div><b>Vanguard Group</b> Inc. raised its stake in shares of Bioamber by 9.9% during the 2nd quarter. <b>Vanguard Group</b> Inc. now owns 303,360 shares of the biotechnology company's stock worth $780,000 after buying an additional 27,278 shares during the last quarter. Finally, Bank of New York Mellon Corp ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up